<?xml version="1.0" encoding="UTF-8"?>
<p>Heat-inactivated (56 °C, 30 min) serum samples were used for VNT performed by using standard procedures [
 <xref rid="B26-vaccines-08-00080" ref-type="bibr">26</xref>]. Titers were expressed as the final dilution of serum present in the serum/virus mixture, where 50% of wells were protected. Antibodies to the non-structural proteins (NSP) of FMDV were detected using the PrioCHECK® FMDV-NS antibody ELISA (ThermoFisher, Waltham, MA, United States of America), with serum samples diluted at 1:5 and tested in duplicate, following the manufacturer’s instructions. Percentage inhibition (PI) values ≥50 were considered positive.
</p>
